v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (36,341) $ (38,097)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 4,881 5,673
Change in fair value of warrant liabilities (1,294) 0
Stock compensation expense 2,510 3,444
Provision for expected credit losses 38 25
Deferred income taxes 89 3
Inventory write-down 2,527 936
Interest expense, related party 2,871 0
Other, net (144) (557)
Changes in current assets and liabilities:    
Accounts receivable, net (1,498) (314)
Accounts receivable from related party 379 392
Inventories (849) (1,437)
Other current assets (1,026) (520)
Accounts payable and accrued liabilities (1,277) (4,770)
Accounts payable to related party 2,728 2,855
Net cash used by operating activities (26,406) (32,367)
Cash flows from investing activities:    
Payment for business acquired (375) 0
Capital expenditures (1,534) (2,043)
Net cash used by investing activities (1,909) (2,043)
Cash flows from financing activities:    
Gross proceeds from the sale of common stock pursuant to the at-the-market public offering (Note 1) 100 0
Payment of offering costs from the at-the-market public offering (Note 1) (3) 0
Payment of borrowings under term loan - related party (Note 12) (800) 0
Repurchase of common stock (861) (759)
Net cash used by financing activities (1,564) (759)
Effect of exchange rate changes on cash and cash equivalents (29) 48
Net decrease in cash and cash equivalents (29,908) (35,121)
Cash and cash equivalents:    
Cash and cash equivalents—beginning of period 82,777 64,437
Net decrease in cash and cash equivalents (29,908) (35,121)
Cash and cash equivalents—end of period $ 52,869 $ 29,316